Home › Companies › BIO-RAD LABORATORIES INC. › 2023-2024

BIO-RAD LABORATORIES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and BIO-RAD LABORATORIES INC.’s Form 8-K, filed April 26, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 6Reported items
  • 129Asset managers
  • 2,081Fund votes
  • April 23, 2024Meeting date

Results at a glance

Meeting of April 23, 2024: 6 items on BIO-RAD LABORATORIES INC.’s Form 8-K, filed April 26, 2024: 6 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIO-RAD LABORATORIES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BIO-RAD LABORATORIES INC.

These tallies are BIO-RAD LABORATORIES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 26, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIO-RAD LABORATORIES INC. — official shareholder meeting results, meeting held April 23, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Melinda Litherland 17,178,5612,491,0178,267 --1,944,423 87%Not verified—
Elect Director: Arnold A. Pinkston 17,412,8972,255,8669,082 --1,944,423 89%Not verified—
Elect Director: Jeffrey L. Edwards 4,992,0383251 --51,564 99.9%Not verified—
Elect Director: Gregory K. Hinckley 4,991,94932590 --51,564 99.9%Not verified—
Elect Director: Allison Schwartz 4,990,9001,37490 --51,564 99.9%Not verified—
Elect Director: Norman Schwartz 4,990,9001,37490 --51,564 99.9%Not verified—

Source: BIO-RAD LABORATORIES INC., Form 8-K, filed with the SEC on April 26, 2024 — read the filing on EDGAR.

How asset managers voted at the BIO-RAD LABORATORIES INC. 2023-2024 meeting

Each item below shows how the 129 asset managers that disclosed a BIO-RAD LABORATORIES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIO-RAD LABORATORIES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Arnold A. Pinkston

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 17,412,897AGAINST: 2,255,866
Details: description as filed, official tally, votes by 126 asset managers

Description as filed by funds: Nominees: Arnold A. Pinkston

BIO-RAD LABORATORIES INC.’s own tally for this item (“Elect Director: Arnold A. Pinkston”): 17,412,897 for, 2,255,866 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 126 asset managers below reported 5,614,850 for, 761,498 against, 835 abstained.

FOR
FOR: 5,614,850AGAINST: 761,498ABSTAIN: 835
Largest asset managers voting on “Nominees: Arnold A. Pinkston” at BIO-RAD LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,317,9030 00For
Fidelity493,070106,808 00Mixed
BlackRock523,514247 00For
Invesco392,9720 00For
Parnassus0237,790 00Against
LONGLEAF PARTNERS FUNDS TRUST233,1240 00For
Charles Schwab0217,933 00Against
State Street206,86111 00For
Dimensional184,5590 00For
Transamerica145,5130 00For
Allspring130,9040 00For
Putnam0102,198 00Against
Investment Managers Series Trust III80,8680 00For
John Hancock79,9140 00For
Artisan62,5820 00For
HARBOR FUNDS58,9140 00For
TIAA58,4590 00For
Brighthouse41,077325 7210For
Gabelli41,5500 00For
Equitable27,91412,343 00Mixed
TRUST FOR PROFESSIONAL MANAGERS35,7130 00For
Mercer Funds35,4250 00For
Virtus35,3760 00For
BUFFALO FUNDS34,0100 00For
MASTER INVESTMENT PORTFOLIO33,0130 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

2. Elect Director: Melinda Litherland

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 17,178,561AGAINST: 2,491,017
Details: description as filed, official tally, votes by 126 asset managers

Description as filed by funds: Nominees: Melinda Litherland

BIO-RAD LABORATORIES INC.’s own tally for this item (“Elect Director: Melinda Litherland”): 17,178,561 for, 2,491,017 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 126 asset managers below reported 5,412,659 for, 963,689 against, 835 abstained.

FORAGAINST
FOR: 5,412,659AGAINST: 963,689ABSTAIN: 835
Largest asset managers voting on “Nominees: Melinda Litherland” at BIO-RAD LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,317,9030 00For
Fidelity493,070106,808 00Mixed
BlackRock523,514247 00For
Invesco392,9720 00For
Parnassus0237,790 00Against
LONGLEAF PARTNERS FUNDS TRUST233,1240 00For
Charles Schwab0217,933 00Against
State Street206,86111 00For
Dimensional0184,559 00Against
Transamerica145,5130 00For
Allspring130,9040 00For
Putnam0102,198 00Against
Investment Managers Series Trust III80,8680 00For
John Hancock65,92413,990 00Mixed
Artisan62,5820 00For
HARBOR FUNDS58,9140 00For
TIAA58,4590 00For
Brighthouse41,077325 7210For
Gabelli41,5500 00For
Equitable27,91412,343 00Mixed
TRUST FOR PROFESSIONAL MANAGERS35,7130 00For
Mercer Funds35,4250 00For
Virtus35,3760 00For
BUFFALO FUNDS34,0100 00For
MASTER INVESTMENT PORTFOLIO33,0130 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

3. Approval of the amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan.

No official matchCOMPENSATION

Combines 2 wordings of this item as funds reported it.

99.7% of fund votes cast · no official result

FOR
Details: votes by 124 asset managers

The 124 asset managers below reported 6,333,056 for, 18,634 against, 1,500 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,333,056AGAINST: 18,634ABSTAIN: 1,500
Largest asset managers voting on “Approval of the amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan.” at BIO-RAD LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,317,9030 00For
Fidelity599,8780 00For
BlackRock523,7610 00For
Invesco392,9720 00For
Parnassus237,7900 00For
LONGLEAF PARTNERS FUNDS TRUST233,1240 00For
Charles Schwab217,9330 00For
State Street206,8702 00For
Dimensional184,5590 00For
Transamerica145,5130 00For
Allspring130,9040 00For
Putnam102,1980 00For
Investment Managers Series Trust III80,8680 00For
John Hancock79,9140 00For
Artisan62,5820 00For
HARBOR FUNDS58,9140 00For
TIAA58,4590 00For
Brighthouse41,7980 00For
Gabelli41,7000 00For
Equitable40,2570 00For
TRUST FOR PROFESSIONAL MANAGERS35,564149 00For
Mercer Funds35,4250 00For
Virtus35,3760 00For
BUFFALO FUNDS34,0100 00For
MASTER INVESTMENT PORTFOLIO33,0130 00For

Showing the 25 largest of 124 asset managers. See all 124 in the interactive database.

4. Amend Omnibus Stock Plan

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 6 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 4 asset managers voting on “Amend Omnibus Stock Plan” at BIO-RAD LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Empower15,6670 00For
Aspiration Funds8,0570 00For
Brighthouse3250 00For
Symmetry Panoramic Trust1080 1140Mixed

Fund voting reports, all 4 managers: 24,157 for, 114 abstained.

Institutional-manager reports: 2 asset managers voting on “Amend Omnibus Stock Plan” at BIO-RAD LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
SECTOR GAMMA AS22,8350 00For
Regime de rentes du Mouvement Desjardins590 00For

Institutional-manager reports, all 2 managers: 22,894 for.

5. Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.

No official matchAUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 122 asset managers

The 122 asset managers below reported 6,347,644 for, 4,397 against, 721 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 6,347,644AGAINST: 4,397ABSTAIN: 721
Largest asset managers voting on “Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.” at BIO-RAD LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,317,9030 00For
Fidelity599,8780 00For
BlackRock523,7610 00For
Invesco392,9720 00For
Parnassus237,7900 00For
LONGLEAF PARTNERS FUNDS TRUST233,1240 00For
Charles Schwab217,9330 00For
State Street206,8702 00For
Dimensional184,5590 00For
Transamerica145,5130 00For
Allspring130,9040 00For
Putnam102,1980 00For
Investment Managers Series Trust III80,8680 00For
John Hancock79,9140 00For
Artisan62,5820 00For
HARBOR FUNDS58,9140 00For
TIAA58,4590 00For
Brighthouse41,0770 7210For
Gabelli41,7000 00For
Equitable40,2570 00For
TRUST FOR PROFESSIONAL MANAGERS35,7130 00For
Mercer Funds35,4250 00For
Virtus35,3760 00For
BUFFALO FUNDS34,0100 00For
MASTER INVESTMENT PORTFOLIO33,0130 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

6. Ratify KPMG LLP as Auditors

No official matchAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: votes by 4 asset managers

The 4 asset managers below reported 24,157 for, 114 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 24,157ABSTAIN: 114
Largest asset managers voting on “Ratify KPMG LLP as Auditors” at BIO-RAD LABORATORIES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Empower15,6670 00For
Aspiration Funds8,0570 00For
Brighthouse3250 00For
Symmetry Panoramic Trust1080 1140Mixed

Largest BIO-RAD LABORATORIES INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,518,000 shares outstanding at the time of that meeting.

Fund voting reports: top BIO-RAD LABORATORIES INC. shareholders by shares voted on “Nominees: Arnold A. Pinkston”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 8.13%
2Fidelity 2.10%
3BlackRock 1.84%
4Invesco 1.38%
5Parnassus 0.83%
6LONGLEAF PARTNERS FUNDS TRUST 0.82%
7Charles Schwab 0.76%
8State Street 0.73%
9Dimensional 0.65%
10Transamerica 0.51%
Institutional-manager reports: top BIO-RAD LABORATORIES INC. shareholders by shares voted on “Amend Omnibus Stock Plan”, 2023-2024
#Asset manager % of shares outstanding
1SECTOR GAMMA AS 0.08%
2Regime de rentes du Mouvement Desjardins <0.01%

Reported BIO-RAD LABORATORIES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

BIO-RAD LABORATORIES INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Vanguard Group 6.29% 13F
BlackRock 5.95% 13F
State Street 3.06% 13F
Geode Capital 1.66% 13F
Invesco 1.62% 13F
Dimensional Fund Advisors 1.06% 13F
Northern Trust 0.89% 13F
Norges Bank 0.79% 13F
Charles Schwab 0.78% 13F
Morgan Stanley 0.61% 13F

Percentages above are of 28,518,000 shares outstanding, as reported by BIO-RAD LABORATORIES INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIO-RAD LABORATORIES INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At BIO-RAD LABORATORIES INC.'s shareholder meeting held April 23, 2024, in the 2023-2024 proxy season, 129 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,081 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Nominees: Arnold A. Pinkston — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BIO-RAD LABORATORIES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 26, 2024.

BIO-RAD LABORATORIES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.